Immune Network Ltd (fka IMMFF)

[lifegear]

Immune Network Ltd. is a biotechnology company focused on the development of new drugs to treat major diseases predominantly involving the body's immune system. The Company's projects include Alzheimer Project AD2 and AIDS Project 1F7 and hNM01, including Hepatitis C Monoclonal Antibodies. During the year ended December 31, 2001, Immune Network suspended various projects due, in part, to fiscal constraints and for commercial reasons, although it has retained an interest in some of the projects by way of royalties in future revenues, if any. Suspended projects include Asthma Project BP1, Eczema Project BP1249, Cancer Project Viraplex, and Herpes Cold Sore Project Zorex.